- Case report
- Open Access
Swedish traveller with Plasmodium knowlesi malaria after visiting Malaysian Borneo
© Bronner et al; licensee BioMed Central Ltd. 2009
- Received: 01 October 2008
- Accepted: 16 January 2009
- Published: 16 January 2009
Plasmodium knowlesi is typically found in nature in macaques and has recently been recognized as the fifth species of Plasmodium causing malaria in human populations in south-east Asia. A case of knowlesi malaria is described in a Swedish man, who became ill after returning from a short visit to Malaysian Borneo in October 2006. His P. knowlesi infection was not detected using a rapid diagnostic test for malaria, but was confirmed by PCR and molecular characterization. He responded rapidly to treatment with mefloquine. Evaluation of rapid diagnostic kits with further samples from knowlesi malaria patients are necessary, since early identification and appropriate anti-malarial treatment of suspected cases are essential due to the rapid growth and potentially life-threatening nature of P. knowlesi. Physicians should be aware that knowlesi infection is an important differential diagnosis in febrile travellers, with a recent travel history to forested areas in south-east Asia, including short-term travellers who tested negative with rapid diagnostic tests.
- Rapid Diagnostic Test
- High Parasitaemias
- Plasmodium Malariae
Plasmodium knowlesi occurs in nature in long-tailed and pig-tailed macaques (Macaca fascicularis and Macaca nemestrina, respectively), that are commonly found in forested areas of south-east Asia . Until a few years ago, infection with P. knowlesi was regarded as a rare disease, occurring only sporadically in humans . The recent findings of a large number of infected patients in Malaysia [3–5], especially in Sarawak, Malaysian Borneo and other reports of human cases acquired in Thailand , Myanmar , the Philippines  and Singapore , have changed the perception of P. knowlesi. This parasite is clearly the fifth species of Plasmodium, causing malaria in humans in south-east Asia . It has the shortest erythrocytic cycle among the primate malarias, only 24 hours , and high parasitaemias with fatal outcome in humans can occur . Under the microscope, it is not possible to distinguish between P. knowlesi and P. malariae due to their similar morphological characteristics [1, 3, 10].
In October 2006, a 35-year-old Swedish man presented to hospital in Stockholm with a two-day history of fever, sweats, headache and fatigue. He had a temperature of 40°C, but was otherwise in good general condition with a normal respiratory rate and blood pressure. Laboratory investigations revealed normal haemoglobin concentration (154 g/L), leucopaenia (2.2 × 109/L), moderate thrombocytopenia (58 × 109/L) and an elevated C-reactive protein concentration of 109 mg/L (normal < 10 mg/L). Plasma creatinine was normal, while plasma bilirubin (31 μmol/L) was just above the upper limit of the normal range and alanine transaminase (1.68 μcat/L) was slightly increased (normal < 1.20 μcat/L).
The nested PCR assay and molecular characterization confirmed that the patient was infected with P. knowlesi. Since the incubation period of P. knowlesi in the liver is 9 to 12 days , this indicates that he most probably acquired his infection while jungle trekking in the Bario Highlands of Sarawak, Malaysian Borneo.
Plasmodium knowlesi parasites morphologically resemble those of P. malariae [1, 2, 10] and PCR assays can correctly differentiate between the two species . However, PCR assays are not a rapid method of detection and are not a viable option for routine diagnosis. Rapid diagnostic tests are becoming an increasingly popular method for diagnosis of malaria , particularly by doctors on call and medical laboratory technologists in non-malaria endemic countries, who are not experienced in identifying malaria parasites by microscopy. It is possible that the low parasitaemia may have been a contributing factor to the inability of the rapid diagnostic test to detect knowlesi malaria in this Swedish patient, since these tests are not as sensitive as microscopy . In a recent study of monoclonal antibodies against Plasmodium lactate dehydrogenase that have been developed for use in a rapid diagnostic test, it was shown that certain antibodies that were thought to be specific for P. falciparum and P. vivax, also bind to P. knowlesi . However, it remains to be determined whether this, and commercially available rapid diagnostic tests, are able to detect P. knowlesi infections by examining a larger number of patient samples.
Early identification and adequate anti-malarial treatment of suspected cases are essential since P. knowlesi has a 24-hr erythrocytic cycle, and high parasitaemias with fatal outcome in humans can occur . Human P. knowlesi infections resolve rapidly following treatment with chloroquine  and the current report indicates that mefloquine is also an effective anti-malarial for knowlesi malaria. However, in severely ill knowlesi malaria patients with high parasitaemias, management and treatment as for severe falciparum malaria has been recommended due to the rapid rate at which P. knowlesi can multiply .
Previous reports of human knowlesi malaria infections were of people that have either lived or worked in the forest and forest fringe areas of south-east Asia . There has been a recent report of a Finnish traveller, who returned from Peninsular Malaysia with knowlesi malaria . Taken together with this report of P. knowlesi infection in a Swedish traveller returning from Malaysian Borneo, this indicates that knowlesi malaria infections in travellers are probably not rare events, particularly since south-east Asia has become a popular tourist destination.
In conclusion, this report shows that P. knowlesi can infect short-term visitors to areas in south-east Asia, where knowlesi transmission occurs, and mefloquine was an effective anti-malarial. The P. knowlesi infection in the Swedish traveller was not detected by a rapid diagnostic test and evaluation of rapid diagnostic tests with further samples are necessary since early identification and appropriate anti-malarial treatment of suspected cases are essential, due to the rapid growth and potentially pathogenic nature of knowlesi malaria. Physicians should, therefore, be aware that knowlesi infection is an important differential diagnosis in febrile travellers with a recent travel history to forested areas in Southeast Asia, including short-term travellers, who tested negative with rapid diagnostic tests.
Written informed consent was obtained from the patient for publication of this case report.
We would like to thank Lillemor Karlsson and Marie Thoren at the Department of Microbiology, Karolinska University Hospital for technical assistance and the patient for allowing us to publish this report. The research of BS and PCSD is supported by a project grant from the Wellcome Trust. The funding body had no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the manuscript and in the decision to submit the manuscript for publication.
- Garnham PCC: Malaria parasites and other haemosporidia. 1966, Oxford: Blackwell Scientific PublicationsGoogle Scholar
- Coatney RG, Collins WE, Warren McW, Contacos PG: The primate malarias. 1971, Washington: US Government Printing OfficeGoogle Scholar
- Singh B, Sung LK, Matusop A, Radhakrishnan A, Shamsul SSG, Cox-Singh J, Thomas AW, Conway D: A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004, 363: 1017-24. 10.1016/S0140-6736(04)15836-4.View ArticlePubMedGoogle Scholar
- Cox-Singh J, Davis TEM, Lee KS, Shamsul SSG, Matusop A, Ratnam S, Rahman HA, Conway DJ, Singh B: Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis. 2008, 46: 165-71. 10.1086/524888.PubMed CentralView ArticlePubMedGoogle Scholar
- Vythilingam I, NoorAzian YM, Huat TC, Jiram AI, Yusri YM, Azahari AH, NorParina I, NoorRain A, LokmanHakim S: Plasmodium knowlesi in humans, macaques and mosquitoes in peninsular Malaysia. Parasit Vectors. 2008, 1: 26-10.1186/1756-3305-1-26.PubMed CentralView ArticlePubMedGoogle Scholar
- Jongwutiwes S, Putaporntip C, Iwasaki T, Sata T, Kanbara H: Naturally acquired Plasmodium knowlesi malaria in human, Thailand. Emerg Infect Dis. 2008, 10 (12): 2211-213.View ArticleGoogle Scholar
- Zhu HM, Li J, Zheng H: Human natural infection of Plasmodium knowlesi. Chinese J Parasitol Parasit Dis. 2006, 24: 70-1.Google Scholar
- Luchavez J, Espino F, Curameng P, Espina R, Bell , Chiodini P, Nolder D, Sutherland C, Lee K-S, Singh B: Human infections with Plasmodium knowlesi, the Philippines. Emerg Infect Dis. 2008, 14: 811-13.PubMed CentralView ArticlePubMedGoogle Scholar
- Ng OT, Ooi EE, Lee CC, Jarrod LP, Ng LC, Wong PS, Ming TT, Phang LJ, Sin LY: Naturally acquired human Plasmodium knowlesi infection, Singapore. Emerg Infect Dis. 2008, 14: 814-16.PubMed CentralView ArticlePubMedGoogle Scholar
- Cox-Singh J, Singh B: Knowlesi malaria: newly emergent and of public health importance?. Trends Parasitol. 2008, 24: 406-410. 10.1016/j.pt.2008.06.001.PubMed CentralView ArticlePubMedGoogle Scholar
- World Health Organization: The use of malaria diagnostic tests. 2004, Manila: WHO Regional Office for the Western Pacific (WPRO)Google Scholar
- Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH: A review of malaria diagnostic tools: Microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg. 2007, 77: 119-127.PubMedGoogle Scholar
- McCutchan TF, Piper RC, Makler MT: Use of malaria rapid diagnostic test to identify Plasmodium knowlesi infection. Emerg Infect Dis. 2008, 14: 1750-1752. 10.3201/eid1411.080480.PubMed CentralView ArticlePubMedGoogle Scholar
- Kantele A, Marti H, Felger I, Müller D, Jokiranta TS: Monkey malaria in a European traveler returning from Malaysia. Emerg Infect Dis. 2008, 14: 1434-1436. 10.3201/eid1409.080170.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.